Skip to main content


  • Oral presentation
  • Open Access

Seven criteria to treat Scheuermann's Disease

Scoliosis20072 (Suppl 1) :S39

  • Published:


  • Public Health
  • Clinical Symptom
  • Early Diagnosis
  • Optimal Treatment
  • Operative Treatment


In our spine center, we observe adolescents who present clinical cases of bony spinal dystrophy during growth, without typical clinical and especially the radiological features of Scheuermann's disease. Such borderline cases ('pre-Scheuermann'?) [1] which cannot be easily classified, need prompt careful and appropriate answers in terms of therapy. We find that existing classifications of Scheuermann's disease are restricting and do not include various types of spinal irregularity and clinical abnormalities of our patients [1]. Our purpose is to present seven criteria to define easily all forms of Scheuermann's disease.

Study design

Four clinical criteria and three radiological criteria are proposed for immediate evaluation of deformity. The clinical criteria are: age, level (classic or atypical), pain, spinal rigidity. The three radiological criteria are: degrees (Cobb), vertebral irregularity, wedging.


We scored the points of each criterion to define the categories of kyphosis and quantify the magnitude of the spinal deformity. These criteria are used easily to recognize all the categories of patients and to describe indications for treatment.


The point of our work is quite practical. Seven criteria are provided to orient diagnosis, anatomic findings, clinical symptoms, radiographic findings, orthotic or other nonoperative treatment with cast, and operative treatment. Early diagnosis, with prompt bracing, is key in optimal treatment.

Authors’ Affiliations

Azienda Ospedaliera Gravina – Caltagirone, via Gulfi n.20, Pedalino c.a.p., 97010, Italy


  1. Wenger DR, Frick SL: Scheuermann's kyphosis. Spine. 1999, 24: 2630-2639. 10.1097/00007632-199912150-00010.View ArticlePubMedGoogle Scholar


© Iemolo; licensee BioMed Central Ltd. 2007

This article is published under license to BioMed Central Ltd.